is retatrutide safe UK Guide: Key Facts on the New Weight-Loss Drug Retatrutide—A Game Changer in Obesity

Patients eligible to enter the trial were 50 years of age or older and had established, stable, CV, cerebrovascular, peripheral artery disease, CKD or NYHA class II and III heart failure or were 60 years of age or older and had other specified risk factors for CV disease

We have been prescribing many long-term drugs for hypertension, heart disease, high cholesterol, diabetes, arthritis, reflux, and many other diseases without hesitation

Over time, this medication may help promote weight loss, especially when paired with a low-fat diet

Exenatide dosage is not recommended to be increased in patients with an estimated glomerular filtration rate (eGFR) of 3060 mL/min/1.73 m 2